Key PointsThe Invesco Nasdaq Biotechnology ETF carries a lower expense ratio and delivered higher total returns over the trailing 12 months than the iShares U.
Read the original report for the complete account of this story.
POLARIS INSIGHTS
Read the original report for the complete account of this story.